Paclitaxel and Carboplatin Concurrent with Radiotherapy for Primary Cervical Cancer

Anticancer Research

Volumn 24, Issue 1, 2004, Pages 345-348

  De Vos, F Y F L ^a   Bos, A M E ^a   Gietema, J A ^a   Pras, E ^a   Van Der Zee, A G J ^a   De Vries, E G E ^a   Willemse, P H B ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Carboplatin; Cervical carcinoma; Chemoradiation; Paclitaxel

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; DIARRHEA; DOSE RESPONSE; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HYSTERECTOMY; LEUKOPENIA; METASTASIS; NAUSEA; PRIORITY JOURNAL; RADIATION ENTEROPATHY; THROMBOCYTOPENIA; URGE INCONTINENCE; UTERINE CERVIX CANCER;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEASIBILITY STUDIES; FEMALE; HUMANS; MIDDLE AGED; PACLITAXEL; RADIOTHERAPY; UTERINE CERVICAL NEOPLASMS;

EID: 1442277068     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL III, Walker JL and Gersell D: Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340: 1154-1161, 1999.
2. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM and Mutch DG: Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340: 1137-1143, 1999.
3. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL and Insalaco S: Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340: 1144-1153, 1999.
4. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, Clarke Pearson DL and Liao SY: Randomised comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynaecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17: 1339-1348, 1999.
5. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M and Williams CJ: Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358: 781-786, 2001.
6. Eifel PJ: Concurrent chemotherapy and radiation: a major advance for women with cervical cancer. J Clin Oncol 17: 1334-1335, 1999.
7. Monaghan J: Time to add chemotherapy to radiotherapy for cervical cancer. Lancet 353: 1288-1289, 1999.
8. Thomas GM: Improved treatment for cervical cancer: concurrent chemotherapy and radiotherapy. N Engl J Med 340: 1198-1200, 1999.
9. Corn BW, Micaily B, Dunton CJ, Heller P, Valicenti RK, Anderson L and Hernandez EI: Concomitant irradiation and dose-escalating carboplatin for locally advanced carcinoma of the uterine cervix: an updated report. Am J Clin Oncol 21: 31-35, 1998.
10. Muderspach LI, Curtin JP, Roman LD, Gebhardt JA, Klement V, Qian D, Morrow CP, Felix JC, Formenti SC and Muggia FM: Carboplatin as a radiation sensitiser in locally advanced cervical cancer: a pilot study. Gynecol Oncol 65: 336-342, 1997.
11. Kudelka AP, Winn R, Edwards CL, Downey G, Greenberg H, Dakhil SR, Freedman RS, LoCoco S, Umbreit J, Delmore JE, Arbuck S, Loyer E, Gacrama P, Fueger R and Kavanagh JJ: An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix. Anticancer Drugs 8: 657-661, 1997.
12. McGuire WP, Blessing JA, Moore D, Lentz SS and Photopulos G: Paclitaxel has moderate activity in squamous cervix cancer. A Gynaecologic Oncology Group study. J Clin Oncol 14: 792-795, 1996.
13. Chen MD, Paley PJ, Potish RA and Twiggs LB: Phase I trial of taxol as a radiation sensitiser with cisplatin in advanced cervical cancer. Gynecol Oncol 67: 131-136, 1997.
14. Piver MS, Ghamande SA, Eltabbakh GH and O'Neill-Coppola C: First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix - a phase II study. Gynecol Oncol 75: 334-337, 1999.
15. Chougule PB, Akhtar MS, Akerley W, Ready N, Safran H, McRae R, Nigri P, Bellino J, Koness J, Radie-Keane K and Wanebo H: Chemoradiotherapy for advanced inoperable head and neck cancer: a phase II study. Semin Radiat Oncol 9: 58-63, 1999.
16. Greco FA, Burris HA, III, Gray JR, Raefsky EL, Dobbs C, Smith S, Rinaldi D, Morrissey LH, Erland JB, Litchy S and Hainsworth JD: Paclitaxel and carboplatin adjuvant therapy alone or with radiotherapy for resected non-small cell lung carcinoma: a feasibility study of the Minnie Pearl Cancer Research Network. Cancer 92: 2142-2147, 2001.
17. Socinski MA, Rosenman JG, Schell MJ, Halle J, Russo S, Rivera MP, Clark J, Limentani S, Fraser R, Mitchell W and Detterbeck FC: Induction carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal thoracic radiation therapy in unresectable stage IIIA/B non-small cell lung carcinoma: a modified phase I trial. Cancer 89: 534-542, 2000.
18. Calvert AH, Newell DR, Gumbrell LA, O'Reilly S, Burnell M, Boxall FE, Siddik ZH, Judson IR, Gore ME and Wiltshaw E: Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 7: 1748-1756, 1989.
19. Choy H, Akerley W, Safran H, Graziano S and Chung C: Paciitaxel plus carboplatin and concurrent radiation therapy for patients with locally advanced non-small cell lung cancer. Semin Oncol 23: 117-119, 1999.
20. Choy H, Devore RF, III, Hande KR, Porter LL, Rosenblatt P, Yunus F, Schlabach L, Smith, Shyr Y and Johnson DH: A phase II study of paclitaxel, carboplatin, and radiation therapy for locally advanced inoperable non-small cell lung (a Vanderbilt Cancer Centre Affiliate Network Study). Int J Radiat Oncol Biol Phys 47: 931-937, 2000.
21. Kemp G, Rose P, Lurain J, Berman M, Manetta A, Roullet B, Homesley H, Belpomme D and Glick J: Amifostine pretreatment for protection against cyclophosphamide-induced cisplatin-induced toxicities: results of a randomised control trial in patients with ovarian cancer. J Clin Oncol 14: 2101-2112, 1996.
22. Pras E, Willemse PH, Boonstra H, Hollema H, Heesters MA, Szabo BG, de Bruijn HW JG and de Vries EG: Concurrent chemo- and radiotherapy in patients with locally carcinoma of the cervix. Ann Oncol 7: 511-516, 1996.
23. Daniele B, Rossi GB, Losito S, Gridelli C and de Bellis M: Ischemic colitis associated with. J Clin Gastroenterol 33: 159-160, 2001.
24. Husain A, Aptaker L, Spriggs DR and Barakat RR: Gastrointestinal toxicity and Clostridium diarrhoea in patients treated with paclitaxel-containing chemotherapy regimens. Oncol 71: 104-107, 1998.
25. Hruban RH, Yardley JH, Donehower RC and Boitnott JK: Taxol toxicity. Epithelial in the gastrointestinal tract associated with polymerised microtubule accumulation mitotic arrest. Cancer 63: 1944-1950, 1989.